Molecular self-assembly has been widely used to develop nanocarriers for drug delivery. However, most of them have unsatisfactory drug loading capacity (DLC) and the dilemma between stimuli-responsiveness and stability, stagnating their translational process. Herein, we overcame these drawbacks using dynamic combinatorial chemistry. A carrier molecule was spontaneously and quantitatively synthesized, aided by co-self-assembly with a template molecule and an anti-cancer drug doxorubicin (DOX) from a dynamic combinatorial library that was operated by disulfide exchange under thermodynamic control. The highly selective synthesis guaranteed a stable yet pH- and redox- responsive nanocarrier with a maximized DLC of 40.1 % and an enhanced drug potency to fight DOX resistance in vitro and in vivo. Our findings suggested that harnessing the interplay between synthesis and self-assembly in complex chemical systems could yield functional nanomaterials for advanced applications.

Download full-text PDF

Source
http://dx.doi.org/10.1002/anie.202010937DOI Listing

Publication Analysis

Top Keywords

dynamic combinatorial
12
drug
5
self-synthesizing nanorods
4
nanorods dynamic
4
combinatorial libraries
4
libraries drug
4
drug resistant
4
resistant cancer
4
cancer molecular
4
molecular self-assembly
4

Similar Publications

Amphiphilic dynamic covalent polymer vectors of siRNA.

Chem Sci

December 2024

Institut des Biomolécules Max Mousseron (IBMM), Université de Montpellier, CNRS, ENSCM Montpellier France

Dynamic covalent polymers (DCPs) recently emerged as smart siRNA delivery vectors, which dynamically self-assemble through siRNA templating and depolymerize in a controlled manner. Herein, we report the dynamic combinatorial screening of cationic and amphiphilic peptide-based monomers. We provide experimental evidence, by mass spectrometry analyses, of the siRNA-templated formation of DCPs, and show that amphiphilic DCPs display superior activity in terms of siRNA complexation and delivery in cells.

View Article and Find Full Text PDF

Novel Tripeptides as Tyrosinase Inhibitors: In Silico and In Vitro Approaches.

Int J Mol Sci

December 2024

Faculty of Chemical Engineering and Technology, Cracow University of Technology, Warszawska 24, 31-155 Kraków, Poland.

Tyrosinase is a key enzyme responsible for the formation of melanin (a natural skin pigment with ultraviolet-protection properties). However, some people experience melanin overproduction, so new, safe, and biocompatible enzyme inhibitors are sought. New tripeptide tyrosinase inhibitors were developed using molecular modeling.

View Article and Find Full Text PDF

Exploring the interaction mechanism between the programmed death-ligand 1 protein and scutellarin via multi-spectroscopy and computer simulation.

Int J Biol Macromol

January 2025

Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences, Wuhan 430071, China; Department of Pharmacy, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China. Electronic address:

Article Synopsis
  • The PD-L1 protein is crucial for immune responses, and this study explores how scutellarin (SCU), a flavonoid, interacts with it.
  • Fluorescence and computer simulations indicate that SCU binds to PD-L1 primarily through static quenching mechanisms, mainly involving hydrogen bonds and van der Waals forces.
  • The study also reveals that SCU alters PD-L1's structure and stability, suggesting its potential as a therapeutic strategy for immune checkpoint blockade and aiding in drug design.
View Article and Find Full Text PDF

Circulating tumor cells (CTCs) drive metastasis, the leading cause of death in individuals with breast cancer. Due to their low abundance in the circulation, robust CTC expansion protocols are urgently needed to effectively study disease progression and therapy responses. Here we present the establishment of long-term CTC-derived organoids from female individuals with metastatic breast cancer.

View Article and Find Full Text PDF
Article Synopsis
  • Optimizing enzyme thermostability is crucial for protein science and industry, but combining multiple mutations can lead to inactivation, making traditional methods slow and inefficient.
  • Researchers developed an AI-driven method to enhance enzyme thermostability by efficiently recombining beneficial single-point mutations, using data from various mutant groups.
  • After two design rounds, the study achieved 50 combinatorial mutants with 100% success, including one exceptional mutant that significantly increased melting temperature and half-life, while also revealing complex interactions (epistasis) among mutations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!